{
  "id": 5461,
  "text": "Radiother Oncol 2005;74:235-245.Available at: http://www.ncbi.nlm.nih.gov/pubmed/15763303.279.Yoshida K, Jastaniyah N, Sturdza A, et al.Assessment of Parametrial Response by Growth Pattern in Patients With International Federation of Gynecology and Obstetrics Stage IIB and IIIB Cervical Cancer: Analysis of Patients From a Prospective, Multicenter Trial (EMBRACE).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Radiother Oncol 2005;74:235-245.Available at: http://www.ncbi.nlm.nih.gov/pubmed/15763303.279.Yoshida K, Jastaniyah N, Sturdza A, et al.Assessment of Parametrial Response by Growth Pattern in Patients With International Federation of Gynecology and Obstetrics Stage IIB and IIIB Cervical Cancer: Analysis of Patients From a Prospective, Multicenter Trial (EMBRACE).\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "宫颈癌患者在接受前瞻性多中心研究如EMBRACE研究时，对于国际妇产科联盟IIB和IIIB期的宫颈癌，宫旁反应的评估涉及多个因素。具体来说，评估宫旁反应与肿瘤生长模式有密切关系。肿瘤生长模式可以影响放射治疗效果及宫旁组织的反应。此外，患者的具体病理特征、治疗方案、以及个体差异也可能会影响宫旁反应的评估结果。这些因素综合起来帮助临床医生更准确地评估肿瘤对治疗的反应，从而优化治疗策略。",
  "query": "患者在接受由多个中心进行的前瞻性研究（如EMBRACE研究）时，国际妇产科联盟IIB和IIIB期宫颈癌的宫旁反应评估与哪些因素有关？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 患者在接受由多个中心进行的前瞻性研究（如EMBRACE研究）时，国际妇产科联盟IIB和IIIB期宫颈癌的宫旁反应评估与哪些因素有关？\n\n<reference text>: Radiother Oncol 2005;74:235-245.Available at: http://www.ncbi.nlm.nih.gov/pubmed/15763303.279.Yoshida K, Jastaniyah N, Sturdza A, et al.Assessment of Parametrial Response by Growth Pattern in Patients With International Federation of Gynecology and Obstetrics Stage IIB and IIIB Cervical Cancer: Analysis of Patients From a Prospective, Multicenter Trial (EMBRACE).\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "宫颈癌患者在接受前瞻性多中心研究如EMBRACE研究时，对于国际妇产科联盟IIB和IIIB期的宫颈癌，宫旁反应的评估涉及多个因素。具体来说，评估宫旁反应与肿瘤生长模式有密切关系。肿瘤生长模式可以影响放射治疗效果及宫旁组织的反应。此外，患者的具体病理特征、治疗方案、以及个体差异也可能会影响宫旁反应的评估结果。这些因素综合起来帮助临床医生更准确地评估肿瘤对治疗的反应，从而优化治疗策略。"
}